Dr. Patrick Forde is a medical oncologist at John Hopkins Medicine who treats patients with lung cancer, mesothelioma, and other thoracic cancers. He completed training in internal medicine and oncology in Ireland prior to undertaking a further fellowship at Johns Hopkins. He is currently associate professor of oncology, associate member of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, and director of John Hopkins’ thoracic oncology clinical research program. Dr. Forde has led development of a clinical-translational research program focused on the immuno-oncology of upper aerodigestive malignancies and has authored publications in New England Journal of Medicine, Nature, and Cancer Discovery among more than 100 peer-reviewed publications. His research examines the role of immunotherapy for early-stage lung cancer. Dr. Forde is principal investigator for the thoracic oncology biospecimen repository at John Hopkins. He is also principal investigator of the international phase 3 registrational trials, CheckMate-816, investigating neoadjuvant chemo-immunotherapy for resectable lung cancer, and DREAM3R, a phase 3 trial of first-line chemo-immunotherapy for mesothelioma.